Article Versions Notes

Nohtani M, Vrzalikova K, Ibrahim M, Powell JE, Fennell É, Morgan S, Grundy R, McCarthy K, Dewberry S, Bouchal J, et al. Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL. Cancers. 2022; 14(17):4297. https://doi.org/10.3390/cancers14174297

Nohtani, Mahdi, Katerina Vrzalikova, Maha Ibrahim, Judith E. Powell, Éanna Fennell, Susan Morgan, Richard Grundy, Keith McCarthy, Sarah Dewberry, Jan Bouchal, and et al. 2022. "Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL" Cancers 14, no. 17: 4297. https://doi.org/10.3390/cancers14174297

Nohtani, M., Vrzalikova, K., Ibrahim, M., Powell, J. E., Fennell, É., Morgan, S., Grundy, R., McCarthy, K., Dewberry, S., Bouchal, J., Bouchalova, K., Kearns, P., & Murray, P. G. (2022). Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL. Cancers, 14(17), 4297. https://doi.org/10.3390/cancers14174297